WorldCare Clinical,LLC (WCC), a leading imaging CRO for clinical trials in the pharmaceutical, biotechnology, and medical device industries, today announced that Richard Walovitch, Ph.D., has joined the organization as chief medical officer. Dr. Walovitch has over twenty years of management experience directing the preclinical and clinical development of therapeutics and diagnostics for pharmaceutical companies of all sizes, and a proven track record in regulatory filings.
In his new position, Walovitch will provide medical leadership for the entire organization by acting as the company’s liaison to its network of physicians and teaching hospitals as well as to its in-house medical expertise through parent company, ProScan Imaging. In addition to providing leadership to the operations and regulatory departments of the organization, Walovitch will provide medical and scientific support to sponsor clinical research teams, study investigators, and WCC project teams.
Prior to joining WCC, Walovitch was the senior vice president of clinical research at Acusphere, Inc., where he was responsible for the development and implementation of worldwide preclinical and clinical strategies for product opportunities in multiple therapeutic areas, including cardiology, oncology, pulmonology, and analgesia. He previously served as vice president of preclinical and clinical research at Epix Medical, which included supervision of Phase I and II clinical trials for an MRI angiography agent, and held various positions as research pharmacologist and project clinician in the Imaging Agent Group at the DuPont Merck Pharmaceutical Company. He completed his postdoctoral fellowship at the National Institute on Drug Abuse’s Addiction Research Center in the Neurochemistry section. Walovitch has a doctorate in pharmacology from the University of Illinois Medical Center and a bachelor’s degree in biology from the University of Illinois. He is an author of more than 100 peer-reviewed publications, mostly in the field of medical imaging.
“We are delighted that Richard has agreed to bring his exceptional experience and leadership skills to WorldCare Clinical,”said Managing Director Michael O’Brien. “His successful track record as a trial management executive, his regulatory approval experience in the U.S. and European markets, and his deep understanding of medical imaging technologies will greatly benefit WorldCare Clinical’s growing business.”